nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Rifampicin—leprosy	0.117	0.147	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.117	0.147	CbGbCtD
Temsirolimus—CYP3A7—Dapsone—leprosy	0.0965	0.121	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0965	0.121	CbGbCtD
Temsirolimus—CYP3A5—Thalidomide—leprosy	0.0905	0.114	CbGbCtD
Temsirolimus—CYP3A5—Rifampicin—leprosy	0.0877	0.11	CbGbCtD
Temsirolimus—CYP3A5—Dapsone—leprosy	0.0724	0.0908	CbGbCtD
Temsirolimus—ABCB1—Rifampicin—leprosy	0.0571	0.0716	CbGbCtD
Temsirolimus—CYP3A4—Rifampicin—leprosy	0.0342	0.0429	CbGbCtD
Temsirolimus—CYP3A4—Dapsone—leprosy	0.0282	0.0354	CbGbCtD
Temsirolimus—Complex regional pain syndrome—Thalidomide—leprosy	0.0206	0.118	CcSEcCtD
Temsirolimus—Phosphorus low—Thalidomide—leprosy	0.0107	0.0619	CcSEcCtD
Temsirolimus—Pneumocystis jirovecii pneumonia—Thalidomide—leprosy	0.00988	0.0569	CcSEcCtD
Temsirolimus—Blood phosphorus decreased—Thalidomide—leprosy	0.00854	0.0492	CcSEcCtD
Temsirolimus—MTOR—hindlimb—leprosy	0.00681	0.229	CbGeAlD
Temsirolimus—MTOR—appendage—leprosy	0.00584	0.197	CbGeAlD
Temsirolimus—Lacrimal structural disorder—Thalidomide—leprosy	0.00422	0.0243	CcSEcCtD
Temsirolimus—Septic shock—Thalidomide—leprosy	0.0041	0.0236	CcSEcCtD
Temsirolimus—MTOR—blood vessel—leprosy	0.00325	0.11	CbGeAlD
Temsirolimus—Intestinal perforation—Thalidomide—leprosy	0.00313	0.0181	CcSEcCtD
Temsirolimus—Lacrimal disorder—Thalidomide—leprosy	0.00277	0.016	CcSEcCtD
Temsirolimus—Aphthous stomatitis—Thalidomide—leprosy	0.00264	0.0152	CcSEcCtD
Temsirolimus—White blood cell count decreased—Thalidomide—leprosy	0.00249	0.0143	CcSEcCtD
Temsirolimus—Embolism venous—Thalidomide—leprosy	0.00246	0.0141	CcSEcCtD
Temsirolimus—Lymphopenia—Thalidomide—leprosy	0.00242	0.0139	CcSEcCtD
Temsirolimus—Venous thrombosis—Thalidomide—leprosy	0.0023	0.0132	CcSEcCtD
Temsirolimus—Vesiculobullous rash—Thalidomide—leprosy	0.00221	0.0127	CcSEcCtD
Temsirolimus—Platelet count decreased—Thalidomide—leprosy	0.00208	0.012	CcSEcCtD
Temsirolimus—Febrile neutropenia—Thalidomide—leprosy	0.00206	0.0119	CcSEcCtD
Temsirolimus—Deep vein thrombosis—Thalidomide—leprosy	0.00204	0.0117	CcSEcCtD
Temsirolimus—Nail disorder—Thalidomide—leprosy	0.00191	0.011	CcSEcCtD
Temsirolimus—Interstitial lung disease—Thalidomide—leprosy	0.00175	0.0101	CcSEcCtD
Temsirolimus—Lung disorder—Thalidomide—leprosy	0.00175	0.0101	CcSEcCtD
Temsirolimus—MTOR—eye—leprosy	0.00173	0.0583	CbGeAlD
Temsirolimus—Hyperlipidaemia—Thalidomide—leprosy	0.00172	0.0099	CcSEcCtD
Temsirolimus—Pleural effusion—Thalidomide—leprosy	0.00162	0.00932	CcSEcCtD
Temsirolimus—FKBP1A—eye—leprosy	0.00156	0.0524	CbGeAlD
Temsirolimus—Rash pustular—Thalidomide—leprosy	0.00155	0.00895	CcSEcCtD
Temsirolimus—Influenza—Dapsone—leprosy	0.00152	0.00875	CcSEcCtD
Temsirolimus—Petechiae—Thalidomide—leprosy	0.00151	0.00867	CcSEcCtD
Temsirolimus—MTOR—skin of body—leprosy	0.0015	0.0507	CbGeAlD
Temsirolimus—Acne—Thalidomide—leprosy	0.00147	0.00848	CcSEcCtD
Temsirolimus—Viral infection—Thalidomide—leprosy	0.00137	0.0079	CcSEcCtD
Temsirolimus—Cellulitis—Thalidomide—leprosy	0.00136	0.00785	CcSEcCtD
Temsirolimus—Hypocalcaemia—Thalidomide—leprosy	0.00135	0.0078	CcSEcCtD
Temsirolimus—FKBP1A—skin of body—leprosy	0.00135	0.0456	CbGeAlD
Temsirolimus—Herpes simplex—Thalidomide—leprosy	0.00134	0.00774	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Thalidomide—leprosy	0.00131	0.00755	CcSEcCtD
Temsirolimus—Creatinine increased—Thalidomide—leprosy	0.0013	0.0075	CcSEcCtD
Temsirolimus—Sinusitis—Dapsone—leprosy	0.00127	0.00732	CcSEcCtD
Temsirolimus—Pulmonary embolism—Thalidomide—leprosy	0.00124	0.00714	CcSEcCtD
Temsirolimus—Phosphatase alkaline increased—Thalidomide—leprosy	0.00124	0.00714	CcSEcCtD
Temsirolimus—Pharyngitis—Dapsone—leprosy	0.00121	0.00695	CcSEcCtD
Temsirolimus—Candida infection—Thalidomide—leprosy	0.00118	0.00681	CcSEcCtD
Temsirolimus—MTOR—tendon—leprosy	0.00115	0.0386	CbGeAlD
Temsirolimus—Rash maculo-papular—Thalidomide—leprosy	0.00113	0.00649	CcSEcCtD
Temsirolimus—Sepsis—Thalidomide—leprosy	0.00108	0.00619	CcSEcCtD
Temsirolimus—Erythema—Dapsone—leprosy	0.00106	0.00609	CcSEcCtD
Temsirolimus—Thrombophlebitis—Thalidomide—leprosy	0.00104	0.00598	CcSEcCtD
Temsirolimus—Diabetes mellitus—Thalidomide—leprosy	0.00103	0.00596	CcSEcCtD
Temsirolimus—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00103	0.00596	CcSEcCtD
Temsirolimus—FKBP1A—tendon—leprosy	0.00103	0.0347	CbGeAlD
Temsirolimus—Eczema—Thalidomide—leprosy	0.001	0.00576	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Thalidomide—leprosy	0.000953	0.00549	CcSEcCtD
Temsirolimus—MTOR—testis—leprosy	0.000948	0.032	CbGeAlD
Temsirolimus—Dermatitis bullous—Thalidomide—leprosy	0.000941	0.00542	CcSEcCtD
Temsirolimus—MTOR—nervous system—leprosy	0.000931	0.0314	CbGeAlD
Temsirolimus—Cough—Dapsone—leprosy	0.000923	0.00532	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000899	0.00518	CcSEcCtD
Temsirolimus—Face oedema—Thalidomide—leprosy	0.000868	0.005	CcSEcCtD
Temsirolimus—FKBP1A—testis—leprosy	0.000853	0.0288	CbGeAlD
Temsirolimus—Blood creatinine increased—Thalidomide—leprosy	0.000843	0.00485	CcSEcCtD
Temsirolimus—FKBP1A—nervous system—leprosy	0.000837	0.0282	CbGeAlD
Temsirolimus—Dehydration—Thalidomide—leprosy	0.000836	0.00482	CcSEcCtD
Temsirolimus—Dry skin—Thalidomide—leprosy	0.000824	0.00475	CcSEcCtD
Temsirolimus—Hypokalaemia—Thalidomide—leprosy	0.000819	0.00471	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00081	0.00466	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Thalidomide—leprosy	0.000793	0.00457	CcSEcCtD
Temsirolimus—Abdominal distension—Thalidomide—leprosy	0.000783	0.00451	CcSEcCtD
Temsirolimus—Insomnia—Dapsone—leprosy	0.000781	0.0045	CcSEcCtD
Temsirolimus—Influenza—Thalidomide—leprosy	0.000777	0.00448	CcSEcCtD
Temsirolimus—Dysphagia—Thalidomide—leprosy	0.000777	0.00448	CcSEcCtD
Temsirolimus—Bronchitis—Thalidomide—leprosy	0.000748	0.00431	CcSEcCtD
Temsirolimus—Neutropenia—Thalidomide—leprosy	0.000727	0.00419	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Thalidomide—leprosy	0.000722	0.00416	CcSEcCtD
Temsirolimus—Pollakiuria—Thalidomide—leprosy	0.000718	0.00414	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Dapsone—leprosy	0.000706	0.00407	CcSEcCtD
Temsirolimus—Weight decreased—Thalidomide—leprosy	0.000703	0.00405	CcSEcCtD
Temsirolimus—Hyperglycaemia—Thalidomide—leprosy	0.000701	0.00404	CcSEcCtD
Temsirolimus—Pneumonia—Thalidomide—leprosy	0.000697	0.00402	CcSEcCtD
Temsirolimus—Infestation—Thalidomide—leprosy	0.000693	0.00399	CcSEcCtD
Temsirolimus—Infestation NOS—Thalidomide—leprosy	0.000693	0.00399	CcSEcCtD
Temsirolimus—Depression—Thalidomide—leprosy	0.000691	0.00398	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000687	0.00396	CcSEcCtD
Temsirolimus—Body temperature increased—Dapsone—leprosy	0.000683	0.00393	CcSEcCtD
Temsirolimus—Abdominal pain—Dapsone—leprosy	0.000683	0.00393	CcSEcCtD
Temsirolimus—Renal failure—Thalidomide—leprosy	0.000681	0.00392	CcSEcCtD
Temsirolimus—ABCB1—blood vessel—leprosy	0.000676	0.0228	CbGeAlD
Temsirolimus—Stomatitis—Thalidomide—leprosy	0.000676	0.00389	CcSEcCtD
Temsirolimus—Conjunctivitis—Thalidomide—leprosy	0.000674	0.00388	CcSEcCtD
Temsirolimus—Haematuria—Thalidomide—leprosy	0.000661	0.00381	CcSEcCtD
Temsirolimus—Epistaxis—Thalidomide—leprosy	0.000654	0.00377	CcSEcCtD
Temsirolimus—Sinusitis—Thalidomide—leprosy	0.00065	0.00375	CcSEcCtD
Temsirolimus—Rhinitis—Thalidomide—leprosy	0.000624	0.00359	CcSEcCtD
Temsirolimus—Pharyngitis—Thalidomide—leprosy	0.000618	0.00356	CcSEcCtD
Temsirolimus—Urinary tract disorder—Thalidomide—leprosy	0.000614	0.00354	CcSEcCtD
Temsirolimus—Oedema peripheral—Thalidomide—leprosy	0.000613	0.00353	CcSEcCtD
Temsirolimus—Urethral disorder—Thalidomide—leprosy	0.00061	0.00351	CcSEcCtD
Temsirolimus—Erythema multiforme—Thalidomide—leprosy	0.000588	0.00339	CcSEcCtD
Temsirolimus—Eye disorder—Thalidomide—leprosy	0.000581	0.00335	CcSEcCtD
Temsirolimus—Cardiac disorder—Thalidomide—leprosy	0.000577	0.00333	CcSEcCtD
Temsirolimus—Angiopathy—Thalidomide—leprosy	0.000565	0.00325	CcSEcCtD
Temsirolimus—Immune system disorder—Thalidomide—leprosy	0.000562	0.00324	CcSEcCtD
Temsirolimus—Mediastinal disorder—Thalidomide—leprosy	0.000561	0.00323	CcSEcCtD
Temsirolimus—Chills—Thalidomide—leprosy	0.000558	0.00322	CcSEcCtD
Temsirolimus—Vomiting—Dapsone—leprosy	0.000549	0.00316	CcSEcCtD
Temsirolimus—Mental disorder—Thalidomide—leprosy	0.000545	0.00314	CcSEcCtD
Temsirolimus—Malnutrition—Thalidomide—leprosy	0.000542	0.00312	CcSEcCtD
Temsirolimus—Headache—Dapsone—leprosy	0.000541	0.00312	CcSEcCtD
Temsirolimus—Dysgeusia—Thalidomide—leprosy	0.00053	0.00306	CcSEcCtD
Temsirolimus—Back pain—Thalidomide—leprosy	0.000524	0.00302	CcSEcCtD
Temsirolimus—Nausea—Dapsone—leprosy	0.000513	0.00295	CcSEcCtD
Temsirolimus—Anaemia—Thalidomide—leprosy	0.000501	0.00288	CcSEcCtD
Temsirolimus—Angioedema—Thalidomide—leprosy	0.000495	0.00285	CcSEcCtD
Temsirolimus—Leukopenia—Thalidomide—leprosy	0.000485	0.00279	CcSEcCtD
Temsirolimus—Cough—Thalidomide—leprosy	0.000473	0.00272	CcSEcCtD
Temsirolimus—Convulsion—Thalidomide—leprosy	0.000469	0.0027	CcSEcCtD
Temsirolimus—Hypertension—Thalidomide—leprosy	0.000468	0.00269	CcSEcCtD
Temsirolimus—Chest pain—Thalidomide—leprosy	0.000461	0.00266	CcSEcCtD
Temsirolimus—Myalgia—Thalidomide—leprosy	0.000461	0.00266	CcSEcCtD
Temsirolimus—Arthralgia—Thalidomide—leprosy	0.000461	0.00266	CcSEcCtD
Temsirolimus—Anxiety—Thalidomide—leprosy	0.00046	0.00265	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000458	0.00264	CcSEcCtD
Temsirolimus—Oedema—Thalidomide—leprosy	0.000442	0.00255	CcSEcCtD
Temsirolimus—Infection—Thalidomide—leprosy	0.000439	0.00253	CcSEcCtD
Temsirolimus—Nervous system disorder—Thalidomide—leprosy	0.000434	0.0025	CcSEcCtD
Temsirolimus—Thrombocytopenia—Thalidomide—leprosy	0.000433	0.00249	CcSEcCtD
Temsirolimus—Skin disorder—Thalidomide—leprosy	0.000429	0.00247	CcSEcCtD
Temsirolimus—Anorexia—Thalidomide—leprosy	0.000421	0.00243	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Thalidomide—leprosy	0.000403	0.00232	CcSEcCtD
Temsirolimus—Insomnia—Thalidomide—leprosy	0.0004	0.0023	CcSEcCtD
Temsirolimus—Dyspnoea—Thalidomide—leprosy	0.000394	0.00227	CcSEcCtD
Temsirolimus—Somnolence—Thalidomide—leprosy	0.000393	0.00226	CcSEcCtD
Temsirolimus—Decreased appetite—Thalidomide—leprosy	0.000384	0.00221	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Thalidomide—leprosy	0.000382	0.0022	CcSEcCtD
Temsirolimus—Fatigue—Thalidomide—leprosy	0.000381	0.0022	CcSEcCtD
Temsirolimus—Pain—Thalidomide—leprosy	0.000378	0.00218	CcSEcCtD
Temsirolimus—Constipation—Thalidomide—leprosy	0.000378	0.00218	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Thalidomide—leprosy	0.000361	0.00208	CcSEcCtD
Temsirolimus—Abdominal pain—Thalidomide—leprosy	0.000349	0.00201	CcSEcCtD
Temsirolimus—Body temperature increased—Thalidomide—leprosy	0.000349	0.00201	CcSEcCtD
Temsirolimus—Hypersensitivity—Thalidomide—leprosy	0.000326	0.00188	CcSEcCtD
Temsirolimus—Asthenia—Thalidomide—leprosy	0.000317	0.00183	CcSEcCtD
Temsirolimus—Pruritus—Thalidomide—leprosy	0.000313	0.0018	CcSEcCtD
Temsirolimus—Diarrhoea—Thalidomide—leprosy	0.000302	0.00174	CcSEcCtD
Temsirolimus—Dizziness—Thalidomide—leprosy	0.000292	0.00168	CcSEcCtD
Temsirolimus—Vomiting—Thalidomide—leprosy	0.000281	0.00162	CcSEcCtD
Temsirolimus—Rash—Thalidomide—leprosy	0.000279	0.00161	CcSEcCtD
Temsirolimus—Dermatitis—Thalidomide—leprosy	0.000278	0.0016	CcSEcCtD
Temsirolimus—Headache—Thalidomide—leprosy	0.000277	0.0016	CcSEcCtD
Temsirolimus—CYP2D6—testis—leprosy	0.000274	0.00925	CbGeAlD
Temsirolimus—CYP3A4—nervous system—leprosy	0.000274	0.00922	CbGeAlD
Temsirolimus—CYP2D6—nervous system—leprosy	0.000269	0.00907	CbGeAlD
Temsirolimus—Nausea—Thalidomide—leprosy	0.000263	0.00151	CcSEcCtD
Temsirolimus—ABCB1—testis—leprosy	0.000197	0.00665	CbGeAlD
Temsirolimus—ABCB1—nervous system—leprosy	0.000194	0.00653	CbGeAlD
